Victrex (VCT) Competitors GBX 960 +12.00 (+1.27%) (As of 09/17/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider Trades VCT vs. JMAT, ELM, ESNT, SCPA, SYNT, TET, ZTF, IOF, WCH, and ITXShould you be buying Victrex stock or one of its competitors? The main competitors of Victrex include Johnson Matthey (JMAT), Elementis (ELM), Essentra (ESNT), Scapa Group (SCPA), Synthomer (SYNT), Treatt (TET), Zotefoams (ZTF), Iofina (IOF), Wilmcote Holdings plc (WCH.L) (WCH), and Itaconix (ITX). These companies are all part of the "specialty chemicals" industry. Victrex vs. Johnson Matthey Elementis Essentra Scapa Group Synthomer Treatt Zotefoams Iofina Wilmcote Holdings plc (WCH.L) Itaconix Johnson Matthey (LON:JMAT) and Victrex (LON:VCT) are both basic materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, community ranking, dividends, valuation, media sentiment, analyst recommendations and institutional ownership. Do institutionals & insiders believe in JMAT or VCT? 65.8% of Johnson Matthey shares are owned by institutional investors. Comparatively, 96.2% of Victrex shares are owned by institutional investors. 0.6% of Johnson Matthey shares are owned by company insiders. Comparatively, 1.7% of Victrex shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media refer more to JMAT or VCT? In the previous week, Victrex had 3 more articles in the media than Johnson Matthey. MarketBeat recorded 4 mentions for Victrex and 1 mentions for Johnson Matthey. Victrex's average media sentiment score of 1.32 beat Johnson Matthey's score of 1.02 indicating that Victrex is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Johnson Matthey 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Victrex 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer JMAT or VCT? Victrex received 22 more outperform votes than Johnson Matthey when rated by MarketBeat users. Likewise, 63.69% of users gave Victrex an outperform vote while only 62.02% of users gave Johnson Matthey an outperform vote. CompanyUnderperformOutperformJohnson MattheyOutperform Votes48562.02% Underperform Votes29737.98% VictrexOutperform Votes50763.69% Underperform Votes28936.31% Which has more volatility & risk, JMAT or VCT? Johnson Matthey has a beta of 0.95, meaning that its stock price is 5% less volatile than the S&P 500. Comparatively, Victrex has a beta of 0.69, meaning that its stock price is 31% less volatile than the S&P 500. Is JMAT or VCT a better dividend stock? Johnson Matthey pays an annual dividend of GBX 77 per share and has a dividend yield of 4.8%. Victrex pays an annual dividend of GBX 60 per share and has a dividend yield of 6.3%. Johnson Matthey pays out 13,275.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Victrex pays out 17,142.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Do analysts rate JMAT or VCT? Johnson Matthey currently has a consensus price target of GBX 1,993.33, indicating a potential upside of 23.73%. Victrex has a consensus price target of GBX 1,485, indicating a potential upside of 55.14%. Given Victrex's higher probable upside, analysts plainly believe Victrex is more favorable than Johnson Matthey.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Johnson Matthey 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50Victrex 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has higher valuation & earnings, JMAT or VCT? Johnson Matthey has higher revenue and earnings than Victrex. Victrex is trading at a lower price-to-earnings ratio than Johnson Matthey, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJohnson Matthey£12.84B0.22£108M£0.582,777.59Victrex£284.10M2.93£30.70M£0.352,734.77 Is JMAT or VCT more profitable? Victrex has a net margin of 10.81% compared to Johnson Matthey's net margin of 0.84%. Victrex's return on equity of 6.36% beat Johnson Matthey's return on equity.Company Net Margins Return on Equity Return on Assets Johnson Matthey0.84% 4.39% 3.41% Victrex 10.81%6.36%6.59% SummaryVictrex beats Johnson Matthey on 12 of the 19 factors compared between the two stocks. Ad Brownstone ResearchIntroducing the PerceptronOn Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. This is my AI project that I first conceived of shortly after I recommended Nvidia back in 2016.Just click here to register. Get Victrex News Delivered to You Automatically Sign up to receive the latest news and ratings for VCT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VCT vs. The Competition Export to ExcelMetricVictrexSpecialty Chemicals IndustryMaterials SectorLON ExchangeMarket Cap£833.03M£8.71B£2.81B£1.42BDividend Yield6.22%4.02%5.33%11.46%P/E Ratio2,734.77295.44122.441,603.61Price / Sales2.93770.69468,615.17173,255.50Price / Cash34.2118.0223.3333.13Price / Book1.818.243.472.85Net Income£30.70M£133.42M£147.39M£153.50M7 Day Performance0.65%0.91%3.54%7.25%1 Month Performance-4.28%3.03%1.59%-1.32%1 Year Performance-34.62%-3.72%19.87%26.79% Victrex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JMATJohnson Matthey2.2574 of 5 stars2.26 / 5 starsGBX 1,591+0.3%GBX 1,993.33+25.3%-9.3%£2.82B£12.84B2,743.10N/ANews CoveragePositive NewsGap UpELMElementis0.6036 of 5 stars0.60 / 5 starsGBX 159.40+0.6%GBX 164.25+3.0%+37.8%£939.06M£732.20M-3,985.001,281ESNTEssentra2.3876 of 5 stars2.39 / 5 starsGBX 165+1.1%GBX 252.50+53.0%+15.0%£474.74M£309.70M7,980.00350News CoverageSCPAScapa Group0 of 5 stars0.00 / 5 starsGBX 214.50flatN/AN/A£402.98M£281.80M-7.321,461SYNTSynthomer2.4858 of 5 stars2.49 / 5 starsGBX 214.33+1.6%GBX 313.33+46.2%+349.9%£350.58M£1.97B-351.364,200Positive NewsTETTreatt0 of 5 stars0.00 / 5 starsGBX 444-0.2%GBX 655+47.5%-10.4%£269.60M£143.55M2,466.67365Dividend IncreaseGap DownZTFZotefoams0 of 5 stars0.00 / 5 starsGBX 426.75-0.8%N/A+23.9%£207.40M£133.40M2,133.75549Positive NewsIOFIofina1.924 of 5 stars1.92 / 5 starsGBX 22+3.5%GBX 35+59.1%-25.1%£42.21M£50.04M733.3395Gap UpWCHWilmcote Holdings plc (WCH.L)0 of 5 stars0.00 / 5 starsGBX 3flatN/A+0.0%£20.13MN/A-5.003ITXItaconix0 of 5 stars0.00 / 5 starsGBX 147.50-1.7%N/A-16.6%£19.90M£7.87M-1,000.0017 Related Companies and Tools Related Companies: Johnson Matthey Alternatives Elementis Alternatives Essentra Alternatives Scapa Group Alternatives Synthomer Alternatives Treatt Alternatives Zotefoams Alternatives Iofina Alternatives Wilmcote Holdings plc (WCH.L) Alternatives Itaconix Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:VCT) was last updated on 9/17/2024 by MarketBeat.com Staff From Our PartnersSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Victrex plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Victrex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.